The Fetal Medicine Foundation 16th World Congress in Fetal Medicine, Ljubljana, Slovenia
Abstracts
 
  • Aneuploidies
  • cfDNA test
  • Defects
    • CNS
    • Face
    • High NT
    • Heart
    • Lungs
    • Gastrointestinal
    • Kidney
    • Skeleton
    • Tumors
    • Placenta
    • Syndromes
    • Other
    • All
  • Fetal therapy
  • Impaired placentation
  • GDM / Obesity
  • Preterm birth
  • Congenital infections
  • Labor / Delivery
  • Maternal conditions
  • Multiple pregnancies
  • Other

cfDNA test

  1. Application of calculating cell-free fetal DNA concentration with the fragment length difference in multiple gestations View pdf
  2. Cell-free DNA testing in twins: application in a tertiary private University Hospital. View pdf
  3. CfDNA testing and risk of fetal aneuploidy in cases with failed results due to low fetal fraction View pdf
  4. Characteristics of women choosing cf-DNA testing in screening for aneuploidies View pdf
  5. Comparison of different characteristics of IVF and non-IVF patients who have opted for the NIPT View pdf
  6. Does cfDNA testing change the spectrum of detected major chromosomal aberrations? View pdf
  7. How NIPT test has changed the prenatal screening in The Ixelles Hospitals form 2010 to 2015 View pdf
  8. Implications of fetoplacental mosaicism on cell-free DNA testing for sex chromosome aneuploidies View pdf
  9. Non invasive prenatal test for duchenne muscular dystrophy View pdf
  10. Non-invasive prenatal testing for aneuploidies - a single center experience View pdf
  11. Non-invasive prenatal tests: impact on a group of Portuguese population View pdf
  12. Noninvasive prenatal testing for fetal trisomies in a routine first-trimester screening setting View pdf
  13. Our experience in applying non-invasive prenatal testing View pdf
  14. Performance of non-invasive prenatal test in India View pdf
  15. Positive testing for trisomy 13 and 18 using cfDNA View pdf
  16. Prenatal screening for 22q11.2 deletions using a targeted microarray - based cell - free (cfDNA) test View pdf
  17. Prospective validation study of the detection rate of Trisomy test for the common trisomies View pdf
  18. Screening strategies for the detection of all fetal karyotype abnormalities View pdf
  19. Single- nucleotide polymorphism-based non-invasive prenatal screening for fetal aneuploidies View pdf
  20. The clinical utility of genome-wide non-invasive prenatal screening View pdf
  21. Use of maternal age or first trimester screening risk in the estimation of trisomy risk in cfDNA screening test View pdf
173721771998230021582068210422931744219322952219196220292214201622562294222719892009
© 2017 The Fetal Medicine Foundation